Actionable answers to guide diagnosis, prognosis, and treatment

An exhaustive test menu includes assays that aid in providing diagnostic and prognostic information and guide treatment choices across the full spectrum of malignancies. Developed and validated in collaboration with practicing oncologists and pathologists, each assay provides information to improve patient care, increase efficiency, and reduce costs. Because genetic testing is about more than mutation identification, we transform complex genetic results into actionable answers to optimize treatment outcomes. 

Featured testing available through Mayo Clinic Laboratories:

LNGPR | Lung Cancer-Targeted Gene Panel with Rearrangement, Tumor

RASFP | RAS/RAF Targeted Gene Panel, Next-Generation Sequencing, Tumor

NONCP | Neuro-Oncology Expanded Gene Panel with Rearrangement, Tumor

SARCP | Sarcoma Targeted Gene Fusion/Rearrangement Panel, Next-Generation Sequencing, Tumor

TMSI | Microsatellite Instability, Tumor

IHC | Mismatch Repair (MMR) Protein Immunohistochemistry Only, Tumor

22C3 | Programmed Death-Ligand 1 (PD-L1) (22C3), Semi-Quantitative Immunohistochemistry, Manual

SP142 | Programmed Death-Ligand 1 (PD-L1) (SP142), Semi-Quantitative Immunohistochemistry, Manual

SP263 | Programmed Death-Ligand 1 (PD-L1) (SP263), Semi-Quantitative Immunohistochemistry, Manual

Featured testing available through American Hospital Dubai:

American Hospital Dubai testing is orderable as code ZW158, Miscellaneous American Hospital Dubai, in the testing catalog.

Alpha fetoprotein

Beta HCG Quantitative

CA 125 Cancer Antigen 125

CA 15-3 Cancer Antigen 15-3

CA 19-9 Cancer Antigen 19-9

Learn more about oncology testing at Mayo Clinic Laboratories.

Contact us